DOI: 10.1016/s1535-6108(04)00083-2. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

10.1016/s1535-6108(04)00083-2

Crossref journal-article

Elsevier BV

Cancer Cell (78)

Bibliography

Franklin, M. C., Carey, K. D., Vajdos, F. F., Leahy, D. J., de Vos, A. M., & Sliwkowski, M. X. (2004). Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex. Cancer Cell, 5(4), 317â328.

Authors 6

Matthew C Franklin (first)
Kendall D Carey (additional)
Felix F Vajdos (additional)
Daniel J Leahy (additional)
Abraham M de Vos (additional)
Mark X Sliwkowski (additional)

References 50 Referenced 927

{'key': '10.1016/S1535-6108(04)00083-2_BIB1', 'first-page': '76', 'article-title': 'A potential role for activated HER-2 in prostate cancer', 'volume': '27', 'author': 'Agus', 'year': '2000', 'journal-title': 'Semin. Oncol.'} / Semin. Oncol. / A potential role for activated HER-2 in prostate cancer by Agus (2000)
10.1016/S1535-6108(02)00097-1 / Cancer Cell / Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth by Agus (2002)
10.1038/348693a0 / Nature / The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily by Aroian (1990)
10.1016/S0014-4827(02)00104-0 / Exp. Cell Res. / ErbB-targeted therapeutic approaches in human cancer by Arteaga (2003)
10.1016/S1097-2765(03)00350-2 / Mol. Cell / An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors by Burgess (2003)
10.1073/pnas.89.10.4285 / Proc. Natl. Acad. Sci. USA / Humanization of an anti-p185HER2 antibody for human cancer therapy by Carter (1992)
10.3233/BD-1999-11109 / Breast Disease / Development of Herceptin by Carter (2000)
10.1126/science.1074611 / Science / Structure of the extracellular region of HER3 reveals an interdomain tether by Cho (2002)
10.1038/nature01392 / Nature / Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab by Cho (2003)
10.1038/74704 / Nat. Med. / Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets by Clynes (2000)
10.1200/JCO.1999.17.9.2639 / J. Clin. Oncol. / Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease by Cobleigh (1999)
10.1006/jmbi.1993.1099 / J. Mol. Biol. / X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling by Eigenbrot (1993)
10.1016/S0014-4827(02)00102-7 / Exp. Cell Res. / Neuregulins by Falls (2003)
{'key': '10.1016/S1535-6108(04)00083-2_BIB14', 'first-page': '1550', 'article-title': 'Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product', 'volume': '50', 'author': 'Fendly', 'year': '1990', 'journal-title': 'Cancer Res.'} / Cancer Res. / Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product by Fendly (1990)
10.1093/emboj/19.17.4632 / EMBO J. / Extracellular domains drive homo- but not hetero-dimerization of erbB receptors by Ferguson (2000)
10.1016/S1097-2765(03)00047-9 / Mol. Cell / EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization by Ferguson (2003)
10.1016/S0014-4827(02)00095-2 / Exp. Cell Res. / Mechanism of action of erbB tyrosine kinase inhibitors by Fry (2003)
10.1016/S0092-8674(02)00940-6 / Cell / Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha by Garrett (2002)
10.1016/S1097-2765(03)00048-0 / Mol. Cell / The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors by Garrett (2003)
10.1093/emboj/16.7.1647 / EMBO J. / ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling by Graus-Porta (1997)
10.1021/bi9614141 / Biochemistry / A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer? by Groenen (1997)
10.1096/fasebj.9.8.7768349 / FASEB J. / Protein kinases 6. The eukaryotic protein kinase superfamily by Hanks (1995)
10.1016/S0014-4827(02)00099-X / Exp. Cell Res. / The ErbB receptors and their role in cancer progression by Holbro (2003)
10.1016/S0021-9258(18)54400-8 / J. Biol. Chem. / Cell transformation potential of a HER2 transmembrane domain deletion mutant retained in the endoplasmic reticulum by Hudziak (1991)
10.1016/S0014-4827(02)00098-8 / Exp. Cell Res. / Epidermal growth factor receptor by Jorissen (2003)
10.1021/bi00139a003 / Biochemistry / Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragments by Kelley (1992)
10.1016/0092-8674(85)90208-9 / Cell / The Drosophila EGF receptor gene homolog by Livneh (1985)
10.1053/gast.2001.24844 / Gastroenterology / Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth by Mann (2001)
{'key': '10.1016/S1535-6108(04)00083-2_BIB29', 'first-page': '5485', 'article-title': 'Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer', 'volume': '62', 'author': 'Mendoza', 'year': '2002', 'journal-title': 'Cancer Res.'} / Cancer Res. / Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer by Mendoza (2002)
{'key': '10.1016/S1535-6108(04)00083-2_BIB30', 'first-page': '4744', 'article-title': 'Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells', 'volume': '61', 'author': 'Molina', 'year': '2001', 'journal-title': 'Cancer Res.'} / Cancer Res. / Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells by Molina (2001)
10.1073/pnas.93.13.6252 / Proc. Natl. Acad. Sci. USA / Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases by Murali (1996)
10.1107/S0907444996012255 / Acta Crystallogr. D / Refinement of Macromolecular Structures by the Maximum-Likelihood Method by Murshudov (1997)
10.1107/S0108767393007597 / Acta Crystallogr. A / AMoRe by Navaza (1994)
10.1016/S0092-8674(02)00963-7 / Cell / Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains by Ogiso (2002)
10.1093/emboj/19.13.3159 / EMBO J. / The ErbB signaling network by Olayioye (2000)
10.1093/protein/3.6.547 / Protein Eng. / Mammalian cell transient expression of tissue factor for the production of antigen by Paborsky (1990)
10.3233/BD-1999-11108 / Breast Disease / HER2 as a predictor of therapeutic response in breast cancer by Paik (2000)
10.1002/stem.160413 / Stem Cells / The HER-2/neu oncogene in breast cancer by Ross (1998)
10.1074/jbc.274.2.859 / J. Biol. Chem. / A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2 by Schaefer (1999)
10.1016/S0092-8674(00)00114-8 / Cell / Cell signaling by receptor tyrosine kinases by Schlessinger (2000)
10.1126/science.3798106 / Science / Human breast cancer by Slamon (1987)
10.1056/NEJM200103153441101 / N. Engl. J. Med. / Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2 by Slamon (2001)
10.1074/jbc.M207135200 / J. Biol. Chem. / Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor by Stamos (2002)
10.1007/s002390010043 / J. Mol. Evol. / Evolutionary analysis of the ErbB receptor and ligand families by Stein (2000)
10.1016/S0022-2836(02)00264-4 / J. Mol. Biol. / Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis by Vajdos (2002)
10.1200/JCO.20.3.719 / J. Clin. Oncol. / Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer by Vogel (2002)
10.1038/314178a0 / Nature / A Drosophila genomic sequence with homology to human epidermal growth factor receptor by Wadsworth (1985)
10.1186/1471-2105-2-4 / BMC Bioinformatics / The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules by Ward (2001)
10.4049/jimmunol.157.11.4986 / J. Immunol. / Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1 by Werther (1996)
10.1038/35052073 / Nat. Rev. Mol. Cell Biol. / Untangling the ErbB signalling network by Yarden (2001)

Dates

Type	When
Created	21 years, 4 months ago (April 21, 2004, 6:28 a.m.)
Deposited	2 years, 4 months ago (April 28, 2023, 8:01 a.m.)
Indexed	1 day, 18 hours ago (Sept. 4, 2025, 9:53 a.m.)
Issued	21 years, 5 months ago (April 1, 2004)
Published	21 years, 5 months ago (April 1, 2004)
Published Print	21 years, 5 months ago (April 1, 2004)

Funders 0

None

BibTeX

@article{Franklin_2004, title={Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex}, volume={5}, ISSN={1535-6108}, url={http://dx.doi.org/10.1016/s1535-6108(04)00083-2}, DOI={10.1016/s1535-6108(04)00083-2}, number={4}, journal={Cancer Cell}, publisher={Elsevier BV}, author={Franklin, Matthew C and Carey, Kendall D and Vajdos, Felix F and Leahy, Daniel J and de Vos, Abraham M and Sliwkowski, Mark X}, year={2004}, month=apr, pages={317–328} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        9,
        4
      ]
    ],
    "date-time": "2025-09-04T13:53:15Z",
    "timestamp": 1756993995877
  },
  "reference-count": 50,
  "publisher": "Elsevier BV",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2004,
            4,
            1
          ]
        ],
        "date-time": "2004-04-01T00:00:00Z",
        "timestamp": 1080777600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    },
    {
      "start": {
        "date-parts": [
          [
            2013,
            7,
            17
          ]
        ],
        "date-time": "2013-07-17T00:00:00Z",
        "timestamp": 1374019200000
      },
      "content-version": "vor",
      "delay-in-days": 3394,
      "URL": "https://www.elsevier.com/open-access/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2004,
        4
      ]
    ]
  },
  "DOI": "10.1016/s1535-6108(04)00083-2",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2004,
        4,
        21
      ]
    ],
    "date-time": "2004-04-21T10:28:17Z",
    "timestamp": 1082543297000
  },
  "page": "317-328",
  "source": "Crossref",
  "is-referenced-by-count": 927,
  "title": "Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex",
  "prefix": "10.1016",
  "volume": "5",
  "author": [
    {
      "given": "Matthew C",
      "family": "Franklin",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "Kendall D",
      "family": "Carey",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Felix F",
      "family": "Vajdos",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Daniel J",
      "family": "Leahy",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Abraham M",
      "family": "de Vos",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "Mark X",
      "family": "Sliwkowski",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB1",
      "first-page": "76",
      "article-title": "A potential role for activated HER-2 in prostate cancer",
      "volume": "27",
      "author": "Agus",
      "year": "2000",
      "journal-title": "Semin. Oncol."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "DOI": "10.1016/S1535-6108(02)00097-1",
      "article-title": "Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth",
      "volume": "2",
      "author": "Agus",
      "year": "2002",
      "journal-title": "Cancer Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "693",
      "DOI": "10.1038/348693a0",
      "article-title": "The let-23 gene necessary for Caenorhabditis elegans vulval induction encodes a tyrosine kinase of the EGF receptor subfamily",
      "volume": "348",
      "author": "Aroian",
      "year": "1990",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "122",
      "DOI": "10.1016/S0014-4827(02)00104-0",
      "article-title": "ErbB-targeted therapeutic approaches in human cancer",
      "volume": "284",
      "author": "Arteaga",
      "year": "2003",
      "journal-title": "Exp. Cell Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "541",
      "DOI": "10.1016/S1097-2765(03)00350-2",
      "article-title": "An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors",
      "volume": "12",
      "author": "Burgess",
      "year": "2003",
      "journal-title": "Mol. Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB6",
      "doi-asserted-by": "crossref",
      "first-page": "4285",
      "DOI": "10.1073/pnas.89.10.4285",
      "article-title": "Humanization of an anti-p185HER2 antibody for human cancer therapy",
      "volume": "89",
      "author": "Carter",
      "year": "1992",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "103",
      "DOI": "10.3233/BD-1999-11109",
      "article-title": "Development of Herceptin",
      "volume": "11",
      "author": "Carter",
      "year": "2000",
      "journal-title": "Breast Disease"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "1330",
      "DOI": "10.1126/science.1074611",
      "article-title": "Structure of the extracellular region of HER3 reveals an interdomain tether",
      "volume": "297",
      "author": "Cho",
      "year": "2002",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "756",
      "DOI": "10.1038/nature01392",
      "article-title": "Structure of the extracellular region of HER2 alone and in complex with the Herceptin Fab",
      "volume": "421",
      "author": "Cho",
      "year": "2003",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "443",
      "DOI": "10.1038/74704",
      "article-title": "Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets",
      "volume": "6",
      "author": "Clynes",
      "year": "2000",
      "journal-title": "Nat. Med."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB11",
      "doi-asserted-by": "crossref",
      "first-page": "2639",
      "DOI": "10.1200/JCO.1999.17.9.2639",
      "article-title": "Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease",
      "volume": "17",
      "author": "Cobleigh",
      "year": "1999",
      "journal-title": "J. Clin. Oncol."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "969",
      "DOI": "10.1006/jmbi.1993.1099",
      "article-title": "X-ray structures of the antigen-binding domains from three variants of humanized anti-p185HER2 antibody 4D5 and comparison with molecular modeling",
      "volume": "229",
      "author": "Eigenbrot",
      "year": "1993",
      "journal-title": "J. Mol. Biol."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "14",
      "DOI": "10.1016/S0014-4827(02)00102-7",
      "article-title": "Neuregulins",
      "volume": "284",
      "author": "Falls",
      "year": "2003",
      "journal-title": "Exp. Cell Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB14",
      "first-page": "1550",
      "article-title": "Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu gene product",
      "volume": "50",
      "author": "Fendly",
      "year": "1990",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "4632",
      "DOI": "10.1093/emboj/19.17.4632",
      "article-title": "Extracellular domains drive homo- but not hetero-dimerization of erbB receptors",
      "volume": "19",
      "author": "Ferguson",
      "year": "2000",
      "journal-title": "EMBO J."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "507",
      "DOI": "10.1016/S1097-2765(03)00047-9",
      "article-title": "EGF activates its receptor by removing interactions that autoinhibit ectodomain dimerization",
      "volume": "11",
      "author": "Ferguson",
      "year": "2003",
      "journal-title": "Mol. Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB17",
      "doi-asserted-by": "crossref",
      "first-page": "131",
      "DOI": "10.1016/S0014-4827(02)00095-2",
      "article-title": "Mechanism of action of erbB tyrosine kinase inhibitors",
      "volume": "284",
      "author": "Fry",
      "year": "2003",
      "journal-title": "Exp. Cell Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "763",
      "DOI": "10.1016/S0092-8674(02)00940-6",
      "article-title": "Crystal structure of a truncated epidermal growth factor receptor extracellular domain bound to transforming growth factor alpha",
      "volume": "110",
      "author": "Garrett",
      "year": "2002",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "495",
      "DOI": "10.1016/S1097-2765(03)00048-0",
      "article-title": "The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation, poised to interact with other ErbB receptors",
      "volume": "11",
      "author": "Garrett",
      "year": "2003",
      "journal-title": "Mol. Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "1647",
      "DOI": "10.1093/emboj/16.7.1647",
      "article-title": "ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling",
      "volume": "16",
      "author": "Graus-Porta",
      "year": "1997",
      "journal-title": "EMBO J."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB21",
      "doi-asserted-by": "crossref",
      "first-page": "3826",
      "DOI": "10.1021/bi9614141",
      "article-title": "A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?",
      "volume": "36",
      "author": "Groenen",
      "year": "1997",
      "journal-title": "Biochemistry"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB22",
      "doi-asserted-by": "crossref",
      "first-page": "576",
      "DOI": "10.1096/fasebj.9.8.7768349",
      "article-title": "Protein kinases 6. The eukaryotic protein kinase superfamily",
      "volume": "9",
      "author": "Hanks",
      "year": "1995",
      "journal-title": "FASEB J."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "99",
      "DOI": "10.1016/S0014-4827(02)00099-X",
      "article-title": "The ErbB receptors and their role in cancer progression",
      "volume": "284",
      "author": "Holbro",
      "year": "2003",
      "journal-title": "Exp. Cell Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "24109",
      "DOI": "10.1016/S0021-9258(18)54400-8",
      "article-title": "Cell transformation potential of a HER2 transmembrane domain deletion mutant retained in the endoplasmic reticulum",
      "volume": "266",
      "author": "Hudziak",
      "year": "1991",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "31",
      "DOI": "10.1016/S0014-4827(02)00098-8",
      "article-title": "Epidermal growth factor receptor",
      "volume": "284",
      "author": "Jorissen",
      "year": "2003",
      "journal-title": "Exp. Cell Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "5434",
      "DOI": "10.1021/bi00139a003",
      "article-title": "Antigen binding thermodynamics and antiproliferative effects of chimeric and humanized anti-p185HER2 antibody Fab fragments",
      "volume": "31",
      "author": "Kelley",
      "year": "1992",
      "journal-title": "Biochemistry"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "599",
      "DOI": "10.1016/0092-8674(85)90208-9",
      "article-title": "The Drosophila EGF receptor gene homolog",
      "volume": "40",
      "author": "Livneh",
      "year": "1985",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB28",
      "doi-asserted-by": "crossref",
      "first-page": "1713",
      "DOI": "10.1053/gast.2001.24844",
      "article-title": "Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth",
      "volume": "120",
      "author": "Mann",
      "year": "2001",
      "journal-title": "Gastroenterology"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB29",
      "first-page": "5485",
      "article-title": "Inhibition of ligand-mediated HER2 activation in androgen-independent prostate cancer",
      "volume": "62",
      "author": "Mendoza",
      "year": "2002",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB30",
      "first-page": "4744",
      "article-title": "Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells",
      "volume": "61",
      "author": "Molina",
      "year": "2001",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB31",
      "doi-asserted-by": "crossref",
      "first-page": "6252",
      "DOI": "10.1073/pnas.93.13.6252",
      "article-title": "Structural analysis of p185c-neu and epidermal growth factor receptor tyrosine kinases",
      "volume": "93",
      "author": "Murali",
      "year": "1996",
      "journal-title": "Proc. Natl. Acad. Sci. USA"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "240",
      "DOI": "10.1107/S0907444996012255",
      "article-title": "Refinement of Macromolecular Structures by the Maximum-Likelihood Method",
      "volume": "53",
      "author": "Murshudov",
      "year": "1997",
      "journal-title": "Acta Crystallogr. D"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB33",
      "doi-asserted-by": "crossref",
      "first-page": "157",
      "DOI": "10.1107/S0108767393007597",
      "article-title": "AMoRe",
      "volume": "50",
      "author": "Navaza",
      "year": "1994",
      "journal-title": "Acta Crystallogr. A"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB34",
      "doi-asserted-by": "crossref",
      "first-page": "775",
      "DOI": "10.1016/S0092-8674(02)00963-7",
      "article-title": "Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains",
      "volume": "110",
      "author": "Ogiso",
      "year": "2002",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "3159",
      "DOI": "10.1093/emboj/19.13.3159",
      "article-title": "The ErbB signaling network",
      "volume": "19",
      "author": "Olayioye",
      "year": "2000",
      "journal-title": "EMBO J."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB36",
      "doi-asserted-by": "crossref",
      "first-page": "547",
      "DOI": "10.1093/protein/3.6.547",
      "article-title": "Mammalian cell transient expression of tissue factor for the production of antigen",
      "volume": "3",
      "author": "Paborsky",
      "year": "1990",
      "journal-title": "Protein Eng."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB37",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "DOI": "10.3233/BD-1999-11108",
      "article-title": "HER2 as a predictor of therapeutic response in breast cancer",
      "volume": "11",
      "author": "Paik",
      "year": "2000",
      "journal-title": "Breast Disease"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB38",
      "doi-asserted-by": "crossref",
      "first-page": "413",
      "DOI": "10.1002/stem.160413",
      "article-title": "The HER-2/neu oncogene in breast cancer",
      "volume": "16",
      "author": "Ross",
      "year": "1998",
      "journal-title": "Stem Cells"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB39",
      "doi-asserted-by": "crossref",
      "first-page": "859",
      "DOI": "10.1074/jbc.274.2.859",
      "article-title": "A discrete three-amino acid segment (LVI) at the C-terminal end of kinase-impaired ErbB3 is required for transactivation of ErbB2",
      "volume": "274",
      "author": "Schaefer",
      "year": "1999",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB40",
      "doi-asserted-by": "crossref",
      "first-page": "211",
      "DOI": "10.1016/S0092-8674(00)00114-8",
      "article-title": "Cell signaling by receptor tyrosine kinases",
      "volume": "103",
      "author": "Schlessinger",
      "year": "2000",
      "journal-title": "Cell"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB41",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "DOI": "10.1126/science.3798106",
      "article-title": "Human breast cancer",
      "volume": "235",
      "author": "Slamon",
      "year": "1987",
      "journal-title": "Science"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB42",
      "doi-asserted-by": "crossref",
      "first-page": "783",
      "DOI": "10.1056/NEJM200103153441101",
      "article-title": "Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2",
      "volume": "344",
      "author": "Slamon",
      "year": "2001",
      "journal-title": "N. Engl. J. Med."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB43",
      "doi-asserted-by": "crossref",
      "first-page": "46265",
      "DOI": "10.1074/jbc.M207135200",
      "article-title": "Structure of the epidermal growth factor receptor kinase domain alone and in complex with a 4-anilinoquinazoline inhibitor",
      "volume": "277",
      "author": "Stamos",
      "year": "2002",
      "journal-title": "J. Biol. Chem."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB44",
      "doi-asserted-by": "crossref",
      "first-page": "397",
      "DOI": "10.1007/s002390010043",
      "article-title": "Evolutionary analysis of the ErbB receptor and ligand families",
      "volume": "50",
      "author": "Stein",
      "year": "2000",
      "journal-title": "J. Mol. Evol."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB45",
      "doi-asserted-by": "crossref",
      "first-page": "415",
      "DOI": "10.1016/S0022-2836(02)00264-4",
      "article-title": "Comprehensive functional maps of the antigen-binding site of an anti-ErbB2 antibody obtained with shotgun scanning mutagenesis",
      "volume": "320",
      "author": "Vajdos",
      "year": "2002",
      "journal-title": "J. Mol. Biol."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB46",
      "doi-asserted-by": "crossref",
      "first-page": "719",
      "DOI": "10.1200/JCO.20.3.719",
      "article-title": "Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer",
      "volume": "20",
      "author": "Vogel",
      "year": "2002",
      "journal-title": "J. Clin. Oncol."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB47",
      "doi-asserted-by": "crossref",
      "first-page": "178",
      "DOI": "10.1038/314178a0",
      "article-title": "A Drosophila genomic sequence with homology to human epidermal growth factor receptor",
      "volume": "314",
      "author": "Wadsworth",
      "year": "1985",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB48",
      "doi-asserted-by": "crossref",
      "first-page": "4",
      "DOI": "10.1186/1471-2105-2-4",
      "article-title": "The relationship between the L1 and L2 domains of the insulin and epidermal growth factor receptors and leucine-rich repeat modules",
      "volume": "2",
      "author": "Ward",
      "year": "2001",
      "journal-title": "BMC Bioinformatics"
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB49",
      "doi-asserted-by": "crossref",
      "first-page": "4986",
      "DOI": "10.4049/jimmunol.157.11.4986",
      "article-title": "Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1",
      "volume": "157",
      "author": "Werther",
      "year": "1996",
      "journal-title": "J. Immunol."
    },
    {
      "key": "10.1016/S1535-6108(04)00083-2_BIB50",
      "doi-asserted-by": "crossref",
      "first-page": "127",
      "DOI": "10.1038/35052073",
      "article-title": "Untangling the ErbB signalling network",
      "volume": "2",
      "author": "Yarden",
      "year": "2001",
      "journal-title": "Nat. Rev. Mol. Cell Biol."
    }
  ],
  "container-title": "Cancer Cell",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1535610804000832?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S1535610804000832?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        28
      ]
    ],
    "date-time": "2023-04-28T12:01:43Z",
    "timestamp": 1682683303000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S1535610804000832"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2004,
        4
      ]
    ]
  },
  "references-count": 50,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2004,
          4
        ]
      ]
    }
  },
  "alternative-id": [
    "S1535610804000832"
  ],
  "URL": "http://dx.doi.org/10.1016/S1535-6108(04)00083-2",
  "relation": {
    "has-review": [
      {
        "id-type": "doi",
        "id": "10.3410/f.1019379.226456",
        "asserted-by": "object"
      },
      {
        "id-type": "doi",
        "id": "10.3410/f.1019379.218525",
        "asserted-by": "object"
      }
    ]
  },
  "ISSN": [
    "1535-6108"
  ],
  "subject": [],
  "container-title-short": "Cancer Cell",
  "published": {
    "date-parts": [
      [
        2004,
        4
      ]
    ]
  }
}